Skip to main content

Table 1 Number of infections in the year preceding the study

From: Clinical efficacy and tolerability of an immune-stimulant* constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study

  Placebo Treated
2 10 (11.4) 11 (12.2)
3 28 (31.8) 22 (24.4)
4 24 (27.3) 20 (22.2)
5 12 (13.6) 18 (20.0)
6 14 (15.9) 19 (21.1)